Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Destra Multi-Alternative Fund (DMA:NYSE), powered by AI.
Destra Multi-Alternative Fund is currently trading at $7.46. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Destra Multi-Alternative Fund on Alpha Lenz.
Destra Multi-Alternative Fund's P/E ratio is -12.2.
“Destra Multi-Alternative Fund trades at a P/E of -12.2 (undervalued) with modest ROE of -5.8%.”
Ask for details →Destra Multi-Alternative Fund is a non-diversified, closed-end interval fund designed to provide investors with a balanced approach to both capital appreciation and consistent income generation. The fund primarily invests in a blend of alternative asset classes, including real estate, direct private equity, alternative credit, and hedge strategies, alongside more traditional holdings such as common stocks and fixed income securities. By emphasizing alternative strategies, Destra Multi-Alternative Fund seeks to deliver long-term returns that are non-correlated to the broader stock and bond markets, serving as a core solution for investors aiming to diversify their portfolios and reduce overall market risk. The fund’s structure permits continuous share offerings and periodic liquidity through its interval mechanism, distinguishing it from traditional closed-end funds and enhancing investor access. Managed by Destra Capital Advisors LLC with Validus Growth Investors as sub-adviser, the fund leverages professional expertise to identify niche opportunities and navigate varying market conditions. It aims to blend income stability with the potential for capital growth, making it a significant player within the alternative investments segment.
“Destra Multi-Alternative Fund trades at a P/E of -12.2 (undervalued) with modest ROE of -5.8%.”
Ask for details →Destra Multi-Alternative Fund (ticker: DMA) is a company listed on NYSE in the Financial Services sector (Asset Management). Market cap is $68M.
The current price is $7.46 with a P/E ratio of -12.23x and P/B of 0.74x.
ROE is -5.78%. Annual revenue is $-4,965,653.